Physician profile
Methodius G Tuuli
NPI 1326225202
$37,354.46
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,051 · 2022: $13K · 2023: $21K · 2024: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Consulting Fee: $9,000 · Honoraria: $3,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,456.05 |
| Consulting Fee | $9,000.00 |
| Honoraria | $3,130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $30,468.33 | 2022-2023 | Monoferric |
| Organon LLC | $3,130.00 | 2023-2024 | |
| Medela Ag | $2,051.32 | 2019 | |
| Shield Therapeutics INC | $1,662.50 | 2022 | |
| Philips North America LLC | $42.31 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Methodius Tuuli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.